Home
Clinical Trials
A Laboratory-based Surveillan...

A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)

Last Updated: 2016-10-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

436 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-04-30

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the incidence rate of Candida blood stream infection (candidemia) among people hospitalized in participating medical centers in Brazil, and will assess the antifungal drug susceptibility patterns of Candida clinical isolates. No hypotheses will be tested in the study. Candida blood stream isolates collected from people hospitalized for any reason during the study period will be sent to a core mycology laboratory for antifungal drug susceptibility testing. All people who develop candidemia while hospitalized will be considered participants in the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care Hospital

NCT00903526

Candidemia

UNKNOWN

Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients

NCT05720728

Candida Infection

COMPLETED

Changing Patterns of Candida Infections in Urban Medical Centers

NCT00366223

Infection Candida Non Albicans Species

COMPLETED

Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients

NCT00304772

Candidiasis Sepsis

WITHDRAWN PHASE4

The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis

NCT05235711

Fungal Infection Candidiasis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Candidemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hospital Candida Cases

People who developed a positive blood culture for Candida while hospitalized

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalized in a participating medical center
* Developed candidemia blood stream infection (confirmed by isolation of Candida species from blood culture)

Eligible Sex

ALL

Accepts Healthy Volunteers